1
|
DNA polymerases and cancer.
|
Nat Rev Cancer
|
2011
|
3.05
|
2
|
ERCC1 and non-small-cell lung cancer.
|
N Engl J Med
|
2007
|
2.22
|
3
|
High-efficiency bypass of DNA damage by human DNA polymerase Q.
|
EMBO J
|
2004
|
2.07
|
4
|
Immunodetection of DNA repair endonuclease ERCC1-XPF in human tissue.
|
Cancer Res
|
2009
|
2.03
|
5
|
DNA polymerase zeta (pol zeta) in higher eukaryotes.
|
Cell Res
|
2008
|
2.02
|
6
|
Vertebrate POLQ and POLbeta cooperate in base excision repair of oxidative DNA damage.
|
Mol Cell
|
2006
|
1.79
|
7
|
POLQ (Pol theta), a DNA polymerase and DNA-dependent ATPase in human cells.
|
Nucleic Acids Res
|
2003
|
1.76
|
8
|
Low-fidelity DNA synthesis by human DNA polymerase theta.
|
Nucleic Acids Res
|
2008
|
1.65
|
9
|
Loss of DNA polymerase zeta causes chromosomal instability in mammalian cells.
|
Cancer Res
|
2006
|
1.60
|
10
|
DNA repair: from molecular mechanism to human disease.
|
DNA Repair (Amst)
|
2006
|
1.56
|
11
|
POLN, a nuclear PolA family DNA polymerase homologous to the DNA cross-link sensitivity protein Mus308.
|
J Biol Chem
|
2003
|
1.53
|
12
|
Human DNA polymerase N (POLN) is a low fidelity enzyme capable of error-free bypass of 5S-thymine glycol.
|
J Biol Chem
|
2006
|
1.49
|
13
|
DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability.
|
Proc Natl Acad Sci U S A
|
2010
|
1.48
|
14
|
DNA polymerases eta and theta function in the same genetic pathway to generate mutations at A/T during somatic hypermutation of Ig genes.
|
J Biol Chem
|
2007
|
1.44
|
15
|
DNA polymerase theta (POLQ) can extend from mismatches and from bases opposite a (6-4) photoproduct.
|
DNA Repair (Amst)
|
2007
|
1.39
|
16
|
DDB1-DDB2 (xeroderma pigmentosum group E) protein complex recognizes a cyclobutane pyrimidine dimer, mismatches, apurinic/apyrimidinic sites, and compound lesions in DNA.
|
J Biol Chem
|
2005
|
1.38
|
17
|
A human DNA helicase homologous to the DNA cross-link sensitivity protein Mus308.
|
J Biol Chem
|
2001
|
1.36
|
18
|
Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines.
|
Int J Cancer
|
2004
|
1.34
|
19
|
Definition of a short region of XPG necessary for TFIIH interaction and stable recruitment to sites of UV damage.
|
Mol Cell Biol
|
2004
|
1.31
|
20
|
XPA protein as a limiting factor for nucleotide excision repair and UV sensitivity in human cells.
|
DNA Repair (Amst)
|
2006
|
1.25
|
21
|
DNA polymerase POLQ and cellular defense against DNA damage.
|
DNA Repair (Amst)
|
2012
|
1.21
|
22
|
Polymorphisms in the human XPD (ERCC2) gene, DNA repair capacity and cancer susceptibility: an appraisal.
|
DNA Repair (Amst)
|
2005
|
1.16
|
23
|
A unique error signature for human DNA polymerase nu.
|
DNA Repair (Amst)
|
2006
|
1.16
|
24
|
DDB complexities.
|
DNA Repair (Amst)
|
2003
|
1.16
|
25
|
Loss of DNA polymerase zeta enhances spontaneous tumorigenesis.
|
Cancer Res
|
2010
|
1.15
|
26
|
Novel enzymatic function of DNA polymerase nu in translesion DNA synthesis past major groove DNA-peptide and DNA-DNA cross-links.
|
Chem Res Toxicol
|
2010
|
1.12
|
27
|
Lesion bypass activity of DNA polymerase θ (POLQ) is an intrinsic property of the pol domain and depends on unique sequence inserts.
|
J Mol Biol
|
2010
|
1.12
|
28
|
DNA polymerases and somatic hypermutation of immunoglobulin genes.
|
EMBO Rep
|
2005
|
1.12
|
29
|
DNA polymerase zeta is required for proliferation of normal mammalian cells.
|
Nucleic Acids Res
|
2012
|
1.05
|
30
|
Lack of DNA polymerase theta (POLQ) radiosensitizes bone marrow stromal cells in vitro and increases reticulocyte micronuclei after total-body irradiation.
|
Radiat Res
|
2009
|
1.03
|
31
|
Elevation of XPA protein level in testis tumor cells without increasing resistance to cisplatin or UV radiation.
|
Mol Carcinog
|
2008
|
1.00
|
32
|
Evolutionary conservation of residues in vertebrate DNA polymerase N conferring low fidelity and bypass activity.
|
Nucleic Acids Res
|
2010
|
1.00
|
33
|
Dual role for mammalian DNA polymerase ζ in maintaining genome stability and proliferative responses.
|
Proc Natl Acad Sci U S A
|
2013
|
0.97
|
34
|
Human DNA helicase HELQ participates in DNA interstrand crosslink tolerance with ATR and RAD51 paralogs.
|
Nat Commun
|
2013
|
0.89
|
35
|
Bypass specialists operate together.
|
EMBO J
|
2009
|
0.88
|
36
|
Salicylanilide inhibitors of Toxoplasma gondii.
|
J Med Chem
|
2012
|
0.87
|
37
|
Assaying for the dual incisions of nucleotide excision repair using DNA with a lesion at a specific site.
|
Methods Mol Biol
|
2006
|
0.86
|
38
|
Combining (1)H NMR spectroscopy and chemometrics to identify heparin samples that may possess dermatan sulfate (DS) impurities or oversulfated chondroitin sulfate (OSCS) contaminants.
|
J Pharm Biomed Anal
|
2010
|
0.84
|
39
|
Replication of the 2,6-diamino-4-hydroxy-N(5)-(methyl)-formamidopyrimidine (MeFapy-dGuo) adduct by eukaryotic DNA polymerases.
|
Chem Res Toxicol
|
2012
|
0.81
|
40
|
Determination of galactosamine impurities in heparin samples by multivariate regression analysis of their (1)H NMR spectra.
|
Anal Bioanal Chem
|
2010
|
0.81
|
41
|
New insights into the combined Cockayne/xeroderma pigmentosum complex: human XPG protein can function in transcription factor stability.
|
Mol Cell
|
2007
|
0.81
|
42
|
Identification of heparin samples that contain impurities or contaminants by chemometric pattern recognition analysis of proton NMR spectral data.
|
Anal Bioanal Chem
|
2011
|
0.78
|
43
|
Repair synthesis assay for nucleotide excision repair activity using fractionated cell extracts and UV-damaged plasmid DNA.
|
Methods Mol Biol
|
2006
|
0.77
|
44
|
Class modeling analysis of heparin 1H NMR spectral data using the soft independent modeling of class analogy and unequal class modeling techniques.
|
Anal Chem
|
2010
|
0.77
|
45
|
Identification of Nitazoxanide as a Group I Metabotropic Glutamate Receptor Negative Modulator for the Treatment of Neuropathic Pain: An In Silico Drug Repositioning Study.
|
Pharm Res
|
2015
|
0.76
|
46
|
Optimisation of the superplastic forming of a dental implant for bone augmentation using finite element simulations.
|
Dent Mater
|
2004
|
0.75
|